Dual acting oximes designed for therapeutic decontamination of reactive organophosphates via catalytic inactivation and acetylcholinesterase reactivation

Jayme Cannon, Shengzhuang Tang, Kelly Yang, Racquel Harrison and Seok Ki Choi

RSC Med. Chem., 2021, 12, 1592
DOI: 10.1039/D1MD00194A

Mannich reaction mediated derivatization of chromones and their biological evaluations as putative multipotent ligands for the treatment of Alzheimer's disease

Naveen Kumar, Kailash Jangid, Vinay Kumar, Bharti Devi, Tania Arora, Jayapriya Mishra, Vijay Kumar, Ashish Ranjan Dwivedi, Jyoti Parkash, Jasvinder Singh Bhatti and Vinod Kumar

RSC Med. Chem., 2024, 15, 4206
DOI: 10.1039/D4MD00550C

Chromone–deferiprone hybrids as novel MAO-B inhibitors and iron chelators for the treatment of Alzheimer's disease

Da-Jiang Zou, Ren-Zheng Liu, Yang-Jing Lv, Jia-Nan Guo, Miao-Liang Fan, Chang-Jun Zhang and Yuan-Yuan Xie

Org. Biomol. Chem., 2024, 22, 6189
DOI: 10.1039/D4OB00919C

An overview on the synthesis of carbohydrate-based molecules with biological activity related to neurodegenerative diseases

João Paulo B. Lopes, Luana Silva and Diogo S. Lüdtke

RSC Med. Chem., 2021, 12, 2001
DOI: 10.1039/D1MD00217A

The recent development of donepezil structure-based hybrids as potential multifunctional anti-Alzheimer's agents: highlights from 2010 to 2020

Rzgar Tawfeeq Kareem, Fahimeh Abedinifar, Evan Abdolkareem Mahmood, Abdol Ghaffar Ebadi, Fatemeh Rajabi and Esmail Vessally

RSC Adv., 2021, 11, 30781
DOI: 10.1039/D1RA03718H

Recent advancements in chromone as a privileged scaffold towards the development of small molecules for neurodegenerative therapeutics

Hari Madhav, Ehtesham Jameel, Mohammad Rehan and Nasimul Hoda

RSC Med. Chem., 2022, 13, 258
DOI: 10.1039/D1MD00394A

New Indole Derivatives As Multitarget anti-Alzheimer's Agents: synthesis, Biological Evaluation and Molecular Dynamics

Eman M Azmy, Ibrahim F Nassar, Mohamed Hagras, Iten M Fawzy, Maghawry Hegazy, Mahmoud Mohamed Mokhtar, Amr Mohamed Yehia, Nasser SM Ismail and Walaa H Lashin

Future Med. Chem., 2023, 15, 473
DOI: 10.4155/fmc-2022-0228

Promising botanical-derived monoamine oxidase (MAO) inhibitors: pharmacological aspects and structure-activity studies

Tuyelee Das, Suchismita Chatterjee Saha, Kumari Sunita, Madhumita Majumder, Mimosa Ghorai, Abhijit Bhagwan Mane, Dorairaj Arvind Prasanth, Prasann Kumar, Devendra Kumar Pandey, Abdel Rahman Al-Tawaha, Gaber El-Saber Batiha, Mahipal S. Shekhawat, Arabinda Ghosh, Javad Sharifi-Rad and Abhijit Dey

South African Journal of Botany, 2022, 146, 127
DOI: 10.1016/j.sajb.2021.09.019

A Recent Appraisal of Small-Organic Molecules as Anti-Alzheimer’s Agents

Mohan Gupta, Avinash Kumar, Madhwi Ojha, Shabana Kausar Khan and Sumitra Nain

MRMC, 2023, 23, 962
DOI: 10.2174/1389557522666220922105934

Design, Synthesis, Molecular Docking, and Molecular Dynamics Simulation Studies of Novel 3‐Hydroxypyridine‐4‐one Derivatives as Potential Acetylcholinesterase Inhibitors

Mohammad Hossein Asgarshamsi, Afshin Fassihi and Mehrdad Mohammadpour Dehkordi

Chemistry & Biodiversity, 2023, 20
DOI: 10.1002/cbdv.202300325

Design, Synthesis and Biological Evaluation of Chromeno[3,4-b]xanthones as Multifunctional Agents for Alzheimer’s Disease

Daniela Malafaia, Natércia F. Brás, Anna Sampietro, Inês Quintelas, Pedro Ferreira, Lúcia Melo, Joana Saavedra, Loreto Martinez-Gonzalez, Marisa Pereira, Jessica Sarabando, Leo König, Isabel Cardoso, Daniela Ribeiro, Ana R. Soares, Raimon Sabaté, Gert Fricker, Ana Martinez, Pedro A. Fernandes, Artur M. S. Silva and Hélio M. T. Albuquerque

ACS Chem. Neurosci., 2025, 16, 3184
DOI: 10.1021/acschemneuro.5c00425

Structure-Based Design of Novel MAO-B Inhibitors: A Review

Emilio Mateev, Maya Georgieva, Alexandrina Mateeva, Alexander Zlatkov, Shaban Ahmad, Khalid Raza, Vasco Azevedo and Debmalya Barh

Molecules, 2023, 28, 4814
DOI: 10.3390/molecules28124814

GC-MS Metabolic Profile and α-Glucosidase-, α-Amylase-, Lipase-, and Acetylcholinesterase-Inhibitory Activities of Eight Peach Varieties

Dasha Mihaylova, Ivelina Desseva, Aneta Popova, Ivayla Dincheva, Radka Vrancheva, Anna Lante and Albert Krastanov

Molecules, 2021, 26, 4183
DOI: 10.3390/molecules26144183

New phenylpiperazine-thiazolidine-2,4-dione hybrids targeting MAO inhibition: Synthesis, biological evaluation, kinetic study and in silico insights

Lamiaa O. El-Halaby, Mohammad M. Al-Sanea, Abdullah A. Elgazar, Samar S. Tawfik, Abdelrahman Hamdi and Wafaa A. Ewes

Bioorganic & Medicinal Chemistry, 2025, 121, 118123
DOI: 10.1016/j.bmc.2025.118123

Structural exploration of multifunctional monoamine oxidase B inhibitors as potential drug candidates against Alzheimer’s disease

Changjun Zhang, Yangjing Lv, Renren Bai and Yuanyuan Xie

Bioorganic Chemistry, 2021, 114, 105070
DOI: 10.1016/j.bioorg.2021.105070

Computational study of 3-thiophene acetic acid: Molecular docking, electronic and intermolecular interactions investigations

Takoua Ben Issa, Abir Sagaama and Noureddine Issaoui

Computational Biology and Chemistry, 2020, 86, 107268
DOI: 10.1016/j.compbiolchem.2020.107268

Amino-7,8-dihydro-4H-chromenone derivatives as potential inhibitors of acetylcholinesterase and butyrylcholinesterase for Alzheimer’s disease management; in vitro and in silico study

Ali Asadipour, Yaghoub Pourshojaei, Moein Mansouri, Elham Mahdavizadeh, Cambyz Irajie, Javad Mottaghipisheh, Ehsan Faghih-Mirzaei, Mohammad Mahdavi and Aida Iraji

BMC Chemistry, 2024, 18
DOI: 10.1186/s13065-024-01170-x

Design, synthesis, and comprehensive evaluation of novel imidazole–chromone hybrids as potent cholinesterase and α-glucosidase inhibitors

Massaab Khalfaoui, Wahiba Frites, Arif Mermer, Dursun Kisa, Buket Yildirim, Mohamed I. Chouiter, Artur M.S. Silva and Houssem Boulebd

European Journal of Medicinal Chemistry, 2025, 297, 117927
DOI: 10.1016/j.ejmech.2025.117927

Multi-Target-Directed Ligands as an Effective Strategy for the Treatment of Alzheimer’s Disease

Bhupinder Kumar, Amandeep Thakur, Ashish Ranjan Dwivedi, Rakesh Kumar and Vinod Kumar

CMC, 2022, 29, 1757
DOI: 10.2174/0929867328666210512005508

Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer′s Disease Therapy

Agnieszka Zagórska and Anna Jaromin

Molecules, 2020, 25, 3337
DOI: 10.3390/molecules25153337

Dual Inhibitors of Acetylcholinesterase and Monoamine Oxidase-B for the Treatment of Alzheimer’s Disease

Ayesha Asim, Michał K. Jastrzębski and Agnieszka A. Kaczor

Molecules, 2025, 30, 2975
DOI: 10.3390/molecules30142975

Synthesis of Chroman-2,4-diones via Ring-Opening/Ring-Closing Reaction Involving Palladium-Catalyzed Intramolecular Aryloxycarbonylation

Sami Chniti, Péter Pongrácz, László Kollár, Attila Bényei, Ágnes Dörnyei and Attila Takács

J. Org. Chem., 2024, 89, 1175
DOI: 10.1021/acs.joc.3c02337

Design, synthesis, and evaluation of novel O -alkyl ferulamide derivatives as multifunctional ligands for treating Alzheimer’s disease

Gaofeng Zhu, Ping Bai, Keren Wang, Jing Mi, Jing Yang, Jiaqi Hu, Yujuan Ban, Ran Xu, Rui Chen, Changning Wang, Lei Tang and Zhipei Sang

Journal of Enzyme Inhibition and Medicinal Chemistry, 2022, 37, 1375
DOI: 10.1080/14756366.2022.2073442

Chromone Containing Hybrid Analogs: Synthesis and Applications in Medicinal Chemistry

Prashant S. Auti, Sakshi Jagetiya and Atish T. Paul

Chemistry & Biodiversity, 2023, 20
DOI: 10.1002/cbdv.202300587

Recent Advances in the Search for Effective Anti-Alzheimer’s Drugs

Martyna Ogos, Dorota Stary and Marek Bajda

IJMS, 2024, 26, 157
DOI: 10.3390/ijms26010157

Monoamine oxidase and neurodegeneration: Mechanisms, inhibitors and natural compounds for therapeutic intervention

Chayan Banerjee, Debasmita Tripathy, Deepak Kumar and Joy Chakraborty

Neurochemistry International, 2024, 179, 105831
DOI: 10.1016/j.neuint.2024.105831

A Concise Review of the Recent Structural Explorations of Chromones as MAO-B Inhibitors: Update from 2017 to 2023

Reshma Susan Ipe, Sunil Kumar, Feba Benny, Jayalakshmi Jayan, Amritha Manoharan, Sachitra Thazhathuveedu Sudevan, Ginson George, Prashant Gahtori, Hoon Kim and Bijo Mathew

Pharmaceuticals, 2023, 16, 1310
DOI: 10.3390/ph16091310

Multi‐Target Drug Design in Alzheimer's Disease Treatment: Emerging Technologies, Advantages, Challenges, and Limitations

Md Saad Hossain and Md Hamed Hussain

Pharmacology Res & Perspec, 2025, 13
DOI: 10.1002/prp2.70131

Selenization of Small Molecule Drugs: A New Player on the Board

Cristina Morán-Serradilla, Daniel Plano, Carmen Sanmartín and Arun K. Sharma

J. Med. Chem., 2024, 67, 7759
DOI: 10.1021/acs.jmedchem.3c02426

The Chemotype of Chromanones as a Privileged Scaffold for Multineurotarget Anti-Alzheimer Agents

Tim Keuler, Carina Lemke, Paul W. Elsinghorst, Isabel Iriepa, Mourad Chioua, María Angeles Martínez-Grau, Christopher D. Beadle, Tatiana Vetman, Francisco López-Muñoz, Timo Wille, Ulrike Bartz, Winnie Deuther-Conrad, José Marco-Contelles and Michael Gütschow

ACS Pharmacol. Transl. Sci., 2022, 5, 1097
DOI: 10.1021/acsptsci.2c00097

Latest advances in dual inhibitors of acetylcholinesterase and monoamine oxidase B against Alzheimer’s disease

Dajiang Zou, Renzheng Liu, Yangjing Lv, Jianan Guo, Changjun Zhang and Yuanyuan Xie

Journal of Enzyme Inhibition and Medicinal Chemistry, 2023, 38
DOI: 10.1080/14756366.2023.2270781

In Vitro and In Vivo Investigations of Chromone Derivatives as Potential Multitarget-Directed Ligands: Cognitive Amelioration Utilizing a Scopolamine-Induced Zebrafish Model

Naveen Kumar, Kailash Jangid, Vishal Kumar, Ravi Prakash Yadav, Jayapriya Mishra, Shubham Upadhayay, Vinay Kumar, Bharti Devi, Vijay Kumar, Ashish Ranjan Dwivedi, Puneet Kumar, Somesh Baranwal, Jasvinder Singh Bhatti and Vinod Kumar

ACS Chem. Neurosci., 2024, 15, 2565
DOI: 10.1021/acschemneuro.4c00007

Inhibition of monoamine oxidases and neuroprotective effects: chalcones vs. chromones

Reshma Ipe, Jong Min Oh, Sunil Kumar, Iqrar Ahmad, Lekshmi R. Nath, Sandeep Bindra, Harun Patel, Krishna Yallappa Kolachi, Prabitha Prabhakaran, Prashant Gahtori, Asad Syed, Abdallah M. Elgorbanh, Hoon Kim and Bijo Mathew

Mol Divers, 2025, 29, 2063
DOI: 10.1007/s11030-024-10959-w

Roles of hybrid donepezil scaffolds as potent human acetylcholinesterase inhibitors using in silico interaction analysis, drug-likeness, and pharmacokinetics prediction

Phujinn Honorio, Supa Hannongbua and Patchreenart Saparpakorn

Chemico-Biological Interactions, 2022, 368, 110227
DOI: 10.1016/j.cbi.2022.110227

N‐Benzyl piperidine Fragment in Drug Discovery

Ankita Sharma, Mohit Sharma and Sandip B. Bharate

ChemMedChem, 2024, 19
DOI: 10.1002/cmdc.202400384

Chromone, A Privileged Scaffold in Drug Discovery: Developments in the Synthesis and Bioactivity

Anjitha Theres Benny, Sonia D. Arikkatt, Cijo George Vazhappilly, Sathananthan Kannadasan, Renjan Thomas, Manju Sreedharan Nair Leelabaiamma, Ethiraj Kannatt Radhakrishnan and Ponnusamy Shanmugam

MRMC, 2022, 22, 1030
DOI: 10.2174/1389557521666211124141859

Alzheimer’s Disease: Treatment of Multi-Factorial Disorders with Multi- Target Approach

Baljit Kaur, Vivesh and Palwinder Singh

MRMC, 2023, 23, 380
DOI: 10.2174/1389557522666220701112048